Delivery Order SPE2DB22D6029-SPE2DB24FU0JC
- Not listed
- On January 7, 2026, the Defense Logistics Agency (DLA) awarded a delivery order valued at approximately $34,000 to AmerisourceBergen Drug Corp for the supply of Leuprolide 2-week 14 mg/2.8 ml kits. The contract is structured as a firm fixed-price delivery order with an ultimate completion date of January 8, 2026, and represents a competitively awarded, non-set-aside procurement. Performance will be executed from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,512.09 firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company, to provide a specific medication, Lupron Depot 45mg. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Leuprolide 2-week 14 mg/2.8 mL kits valued at $17,974.79 with a firm fixed price structure. The contract is non-competitive with no set-aside designation and is scheduled for completion by September 29, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with Defense Logistics...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,651.81, is a delivery order for the supply of Leuprolide 2 Week 14 mg/2.8 ml Kits. The contract has an ultimate completion date of August 22, 2024 and is a Firm Fixed Price contract type. Amerisourcebergen, through its Corporate Office division, will be delivering these critical pharmaceutical products to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order valued at $4,926.04 to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the supply of LUPRON DEPOT 11.25 MG 3MO KITS, with a performance period ending on May 10, 2024. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a specialty medication, with a ceiling value of $3,570.36 and a period of performance through February 25, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $34,774.88 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide LEUPROLIDE 2WK 14 MG/2.8 ML KTS pharmaceutical products. This order falls under an indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of $999,999,999.00 and a period of performance through December 31, 2025. The IDC serves as the primary...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is valued at $2,217.36 and is for the delivery of the pharmaceutical product Leuprolide 2WK 14 mg/2.8 ml kits. The contract is a Firm Fixed Price (FFP) delivery order, with no set-aside designation. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to...
- The Defense Logistics Agency (DLA) awarded a delivery order to Amerisourcebergen Drug Corp., the Corporate Office division of Amerisourcebergen Corporation, a major pharmaceutical distributor. The $14,918.85 firm-fixed-price order is for the supply of 4,564,885,604 units of the drug Lupron Depot 3.75 mg kits. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical to provide a comprehensive...
- This is a federal contract award issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,397.44, is a Firm Fixed Price Delivery Order for the supply of LEUPROLIDE 2WK 14 MG/2.8 ML KTS, a specialty medication. The award has an ultimate completion date of January 29, 2025. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- SPE2DB22D6029Indefinite Delivery Contract
- SPE2DB22D6029-SPE2DB24FU0JCDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,869.12 to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of leuprolide, a specialty injectable medication, to support military treatment programs and facilities. This delivery order was issued under an existing indefinite delivery contract (IDC) between DLA and AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 2025. The IDC serves as the primary contract vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. No set-aside designation was used for this contract award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 3/19/24 |